FDA - McKnight's Long Term Care News

FDA

Clinical Briefs for Tuesday, June 16

FDA revokes emergency use status for hydroxychloroquine … Eli Lilly launches trial of arthritis drug to treat COVID-19 … Long-term, phase-2 trial to study potential Alzheimer’s medication … Once-weekly insulin shows promise in early trial … Disrupted sleep rhythms in older men linked to later Parkinson’s diagnosis

Clinical Briefs for Tuesday, June 2

First federal count: more than 25,000 coronavirus deaths in nursing homes … AstraZeneca’s heart drug for high-risk patients receives FDA approval … Senior living operator balances safety, quality of life in the COVID-19 era … U.S. hospitals slash hydroxychloroquine use after studies reveal risks, suggest ineffectiveness … CDC: U.S. COVID-19 transmission likely began in January

Clinical Briefs for Thursday, April 23

New technology could block the coronavirus from infecting human cells … Industry at a ‘severe disadvantage’ identifying asymptomatic residents and staff: AHCA/NCAL … Second COVID-19 wave in winter could be worse … Metabolic syndrome and osteopenia in older women tied to socioeconomic status … FDA: Pharmacies may temporarily compound COVID-19 drugs without prescriptions

Clinical Briefs for Monday, April 13

More than 2,200 COVID-19 deaths in nursing homes … Lack of data, testing puts residents at risk of coronavirus: provider survey … More evidence found that ultrasound can aid in delivering future Alzheimer’s treatments … FDA approves first generic albuterol inhaler to meet rising demand

Next post in Clinical Daily News